Lilly not slashing force like its rivals

Share this article:
Eli Lilly CEO Sidney Taurel said the company does not plan any major changes to its sales force, even as rivals cut jobs.

“We won’t grow our sales force,” Taurel said in an interview with the cable network CNBC. “There has been some reduction…of our sales force. But we don’t see major decreases.”

Taurel said Lilly has already decreased its total work force by 4,500, or 10%, since 2004.

Late 2006, Pfizer announced cuts to its US and European sales forces by at least 20%. AstraZeneca said it plans to cut 3,000 jobs, or 4.6% of its workforce. Abbott also announced the phasing out of “several hundred” primary care rep positions.

Share this article:
close

Next Article in News

Email Newsletters

More in News

BMS Q2 sales slip, Eliquis, Yervoy soar

BMS Q2 sales slip, Eliquis, Yervoy soar

The company attributed part of the Eliquis boost to the BMS-Pfizer DTC and education efforts.

Gilead, Merck HCV marketing battle may be on horizon

Gilead, Merck HCV marketing battle may be on ...

Disclosed in its earnings report yesterday, Gilead may have a card up its sleeve to counter Merck's experimental hep. C combo regimen.

Sales of Biogen MS pill pick up overseas

Sales of Biogen MS pill pick up overseas

Biogen Idec is seeing strong sales for blockbuster MS drug Tecfidera, especially overseas where it's beginning to catch fire this summer.